TEM

Tempus AI Inc

77.84

Sep 18 • 3:59 PM ET -2.52 (-3.14%)

77.84

Aftermarket • 7:58 PM ET 0.00 (0.00%)

Healthcare Health Information Services USA Large NASD

Sep 17, 10:02 AMCEO’s Morgan Stanley pricing outlook extends Tempus AI rally another 11% Thursday

Peers: VEEV DOCS AI EVH PHR HCAT PLTR TDOC BBAI DH

| Held by: ARKE ARKK VTI ARKG VB VBK VXF IBB JTEK ARTY

Index	-
Market Cap	14.05B
Enterprise Value	14.67B
Income	-254.43M
Sales	1.43B
Book/sh	2.47
Cash/sh	4.52
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	3800
IPO	Jun 14, 2024

P/E	-
Forward P/E	2008.77
PEG	-
P/S	9.81
P/B	31.50
P/C	17.21
P/FCF	-
EV/EBITDA	-
EV/Sales	10.25
Quick Ratio	3.16
Current Ratio	3.30
Debt/Eq	3.25
LT Debt/Eq	3.22
Option/Short	Yes / Yes

EPS (ttm)	-1.44
EPS next Y	0.04
EPS next Q	-0.08
EPS this Y	64.68%
EPS next Y	117.99%
EPS next 5Y	-
EPS past 3/5Y	10.57% 1.21%
Sales past 3/5Y	58.29% 46.57%
EPS Y/Y TTM	-21.05%
Sales Y/Y TTM	50.43%
EPS Q/Q	112.51%
Sales Q/Q	21.56%
Earnings	Jul 30 AMC
EPS/Sales Surpr.	71.99% 0.74%

Insider Own	40.30%
Insider Trans	-2.46%
Inst Own	55.99%
Inst Trans	4.27%
ROA	-12.75%
ROE	-67.44%
ROIC	-13.56%
Gross Margin	62.92%
Oper. Margin	-18.92%
Profit Margin	-17.77%
SMA20	17.06%
SMA50	36.41%
SMA200	38.62%
Trades

Shs Outstand	175.02M
Shs Float	107.73M
Short Float	27.35%
Short Ratio	4.55
Short Interest	29.46M
52W High	104.32 -25.38%
52W Low	40.77 90.92%
Volatility	8.86% 7.90%
ATR (14)	4.94
RSI (14)	67.82
Beta	3.53
Rel Volume	1.44
Avg Volume	6.48M
Volume	9,321,155

Perf Week	31.91%
Perf Month	27.09%
Perf Quarter	53.11%
Perf Half Y	59.70%
Perf YTD	31.82%
Perf Year	-10.60%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	2.18
Target Price	67.53
Prev Close	80.36
Price	77.84
Change %	-3.14%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Initiated	UBS	Neutral	$70
Sep-08-26	Initiated	Rothschild & Co Redburn	Neutral	$67
Sep-02-26	Initiated	Cantor Fitzgerald	Overweight	$80
Sep-01-26	Upgrade	Piper Sandler	Neutral → Overweight	$76
Jun-02-26	Resumed	Wolfe Research	Peer Perform
Apr-13-26	Upgrade	TD Cowen	Hold → Buy	$65
Apr-13-26	Initiated	Jefferies	Underperform	$35
Feb-19-26	Initiated	Mizuho	Outperform	$100
Feb-17-26	Initiated	Robert W. Baird	Outperform	$59
Dec-02-25	Resumed	Morgan Stanley	Overweight	$85
Oct-21-25	Downgrade	TD Cowen	Buy → Hold	$88
Oct-20-25	Initiated	Canaccord Genuity	Buy	$110
Sep-02-25	Initiated	H.C. Wainwright	Buy	$90
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65

Show Previous Ratings

Sep-18-26 05:38PM	The ARK Trade Watch: Cathie Wood Cuts Crypto Exposure, Then Reverses Course On CoreWeave (Stocktwits)
Sep-17-26 03:52PM	Will 2026 Doom and Gloom Lead to Opportunity? (Zacks) +14.85%
02:34PM	Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak (Barrons.com)
Sep-14-26 02:40PM	Tempus AI CEO Eric Lefkofsky: Healthcare will likely be the biggest beneficiary of AI (CNBC TV) +5.42%
10:00AM	AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 (PR Newswire)
08:30AM	Loading…
Sep-11-26 08:30AM	Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation (Business Wire)
Sep-09-26 04:01PM	Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology (Business Wire)
09:12AM	Cathie Wood Grows Robinhood Stake; Sheds More AMD, Palantir (Investor's Business Daily)
Sep-07-26 09:49PM	The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI (BeInCrypto)
Sep-04-26 08:30AM	Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference (Business Wire)
05:30AM	The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels. (The Wall Street Journal)
Sep-03-26 08:55AM	AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 (PR Newswire)
Sep-02-26 09:54AM	Sirius XM upgraded, Toast downgraded: Wall Street's top analyst calls (The Fly)
Sep-01-26 09:48AM	Cathie Wood Sold $26 Million of Palantir to Buy These Two Stocks (GuruFocus.com)
09:45AM	Piper Sandler Lifts Tempus AI to Overweight at $76 (GuruFocus.com)
09:36AM	Loading…
09:36AM	Robinhood upgraded, Uber initiated: Wall Street's top analyst calls (The Fly)
09:36AM	Tempus AI shares rise 2.7% following analyst actions (InvestorsHub)
06:54AM	What Is Cathie Wood Buying Now? Nvidia, SpaceX And Crypto Stocks Led ARKs August Trades While Cutting These Growth Stocks (Stocktwits)
Aug-25-26 11:01PM	Tongcheng Travel Holdings Ltd (STU:TEM) (Q2 2026) Earnings Call Highlights: Resilient Growth ... (GuruFocus.com)
Aug-24-26 02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis) -8.97%
08:30AM	Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs (Business Wire)
Aug-20-26 01:22PM	TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight (Stocktwits) +8.82%
Aug-19-26 01:49PM	TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial (Stocktwits) +24.09%
Aug-06-26 09:15AM	CellCarta Adds Tempus to CDx Commercialization Lab Network (PR Newswire)
Aug-04-26 08:30AM	Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications (Business Wire)
Jul-31-26 01:12PM	Beyond Mega IPOs: ICR Capital President & Chairman Don Duffy, Live from NYSE (IPO-Edge.com)
01:02AM	Tempus AI Inc (TEM) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% to $382. ... (GuruFocus.com)
Jul-30-26 04:14PM	Tempus: Q2 Earnings Snapshot (Associated Press) +6.59%
04:01PM	Tempus Reports Second Quarter 2026 Results (Business Wire)
Jul-24-26 09:10AM	A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed (PR Newswire) -7.22%
07:30AM	Loading…
07:30AM	Cathie Wood's Ark Bought the Dip in Tesla Stock (Barrons.com)
Jul-22-26 08:30AM	Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine (Business Wire)
Jul-21-26 08:40AM	Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal (Quartz)
08:30AM	Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion (Quartz)
07:43AM	Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal (Medical Device Network)
Jul-20-26 04:56PM	Tempus AI Buys Personalis in $1.7 Billion Precision Oncology Deal (GuruFocus.com) -7.74%
03:38PM	TEM, PSNL Stocks Are Falling Why Morgan Stanley Still Likes Tempus AIs Personalis Deal (Stocktwits)
11:31AM	Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive (Investor's Business Daily)
11:23AM	Tempus AI to acquire cancer-monitoring firm Personalis for $1.5B (Proactive)
11:11AM	TEMs Deal To Acquire PSNL Opens Door For $20B Cancer Market Opportunity Retail Awaits To See Execution (Stocktwits)
10:44AM	Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink (Barrons.com)
10:38AM	Tempus to buy cancer test-maker Personalis for $1.5B (MedTech Dive)
08:35AM	Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform (Business Wire)
Jul-17-26 09:42AM	Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies. (Investor's Business Daily)
Jul-09-26 09:00AM	Tempus to Report Second Quarter 2026 Financial Results on July 30 (Business Wire) +7.39%
Jul-02-26 06:41PM	CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology (Exec Edge)
Jul-01-26 10:46PM	TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' Story (Stocktwits) +6.34%
08:00PM	5 Under-the-Radar Stocks Fueling the AI Revolution (Oilprice.com)
09:04AM	Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX (GuruFocus.com)
09:00AM	As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data (PR Newswire)
Jun-25-26 08:30AM	Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers (Business Wire) +5.64%
Jun-16-26 09:11AM	16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap (PR Newswire)
Jun-11-26 08:30AM	Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm (Business Wire)
Jun-09-26 06:00AM	Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal RNA Testing Can Improve Diagnostic Clarity in Exome Testing (Business Wire)
Jun-05-26 04:01PM	Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference (Business Wire) -11.16%
Jun-03-26 08:30AM	Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members (Business Wire)
Jun-01-26 08:30AM	Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH (Business Wire)
May-31-26 08:30AM	Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development (Business Wire)
May-30-26 08:30AM	Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community (Business Wire)
08:00AM	Tempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results (Business Wire)
May-29-26 09:15AM	Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology (Business Wire)
08:15AM	Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio (Business Wire)
May-28-26 08:30AM	Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology (Business Wire) +8.73%
May-27-26 08:33AM	Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows (Business Wire)
May-26-26 08:30AM	Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting (Business Wire)
May-20-26 02:19PM	4 Heavily Shorted AI Stocks to Watch Right Now (Schaeffer's Research)
May-19-26 08:55AM	Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts (PR Newswire)
May-14-26 06:15PM	Imvivas CTA313 Lupus Drug Shows Promising Remission Results (Exec Edge)
08:30AM	Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience (Business Wire)
May-11-26 06:00AM	Ambry Genetics' CARE Program Wins 2026 MedTech Breakthrough Award for "Best Overall Health Informatics Solution" (Business Wire)
May-08-26 12:59AM	Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes (Business Wire)
May-07-26 07:11AM	Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense (Business Wire) -7.53%
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
May-05-26 08:21PM	Tempus AI, Inc. Q1 2026 Earnings Call Summary (Moby)
04:01PM	Tempus Reports First Quarter 2026 Results (Business Wire)
Apr-29-26 08:30AM	Tempus to Host Inaugural Investor Day on May 29, 2026 (Business Wire)
Apr-28-26 08:30AM	Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 (Business Wire)
Apr-23-26 08:30AM	Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine (Business Wire) -7.33%
Apr-21-26 08:30AM	Tempus to Report First Quarter 2026 Financial Results on May 5 (Business Wire)
Apr-15-26 08:30AM	Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring (Business Wire) +13.89%
Apr-14-26 08:30AM	Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026 (Business Wire) +7.72%
Apr-13-26 09:58AM	Nike downgraded, Starbucks upgraded: Wall Street's top analyst calls (The Fly) +7.08%
08:30AM	Tempus Launches Automated "Active Follow-Up" Service to Support Guideline-Concordant Care (Business Wire)
Apr-09-26 08:30AM	Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE (Business Wire) -7.03%
Apr-08-26 04:01PM	Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-26-26 08:57AM	Cathie Wood's Ark Dumped More Meta Stock-and Loaded Up on Another AI Stock Instead (Barrons.com)
06:34AM	Daiichi Sankyo and Tempus AI collaborate on ADC clinical development (Pharmaceutical Business Review)
04:36AM	Meta Stock Dumped by Cathie Wood. Her ARK Funds Go Big On This AI Play Instead. (Barrons.com)
Mar-24-26 03:01PM	Tongcheng Travel Holdings Ltd (FRA:TEM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Mar-17-26 08:30AM	Tempus and Blood Cancer United Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries (Business Wire)
Mar-11-26 08:30AM	Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings (Business Wire)
Mar-10-26 01:33PM	Hims and Hers Expands Consumer-Focused Digital Health Platform (Zacks)
Mar-09-26 08:52AM	Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? (Zacks)
Mar-07-26 07:11AM	Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine (Insider Monkey)
Mar-05-26 08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 06:00PM	Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? (Insider Monkey)
Mar-03-26 02:33PM	AI-Powered Tempus Inks New Multi-Year Merck Deal (Benzinga)
12:19PM	Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes (PR Newswire)
08:30AM	Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine (Business Wire)
Mar-01-26 08:00AM	Consumer Tech News (Feb 23-27): US-Taiwan Trade Tensions Escalates, Amazon Invests $12B In US & More (Benzinga)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Co-FounderMr. Eric P. Lefkofsky J.D.

Chief Financial OfficerMr. James Rogers

Executive VP and Chief Administrative & Legal OfficerMr. Erik Phelps

Chief Legal OfficerMr. Andrew Polovin

Chief Executive Officer of Data & AppsMr. Ryan Fukushima

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LEFKOFSKY ERIC P	CEO and Chairman	Sep 17 '26	Sale	80.57	200,000	16,113,802	809,631	Sep 18 09:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Sep 17 '26	Sale	75.00	7,062	529,650	60,804	Sep 18 09:15 PM
Polovin Andrew	EVP, Chief Legal Officer	Sep 17 '26	Sale	75.00	2,951	221,325	135,189	Sep 18 09:15 PM
Fukushima Ryan	CEO, Data	Sep 16 '26	Sale	70.00	700	49,000	15,874	Sep 18 09:15 PM
Eric Lefkofsky	Officer	Sep 17 '26	Proposed Sale	69.97	200,000	13,994,000		Sep 17 05:06 PM
RYAN BARTOLUCCI	Officer	Sep 17 '26	Proposed Sale	69.97	9,311	651,491		Sep 17 04:31 PM
ANDREW POLOVIN	Officer	Sep 17 '26	Proposed Sale	69.97	2,951	206,481		Sep 17 04:28 PM
VANESSA KUBO	Officer	Sep 16 '26	Proposed Sale	68.85	700	48,195		Sep 16 04:31 PM
JENNIFER DOUDNA	Director	Sep 01 '26	Proposed Sale	63.05	676	42,622		Sep 01 04:52 PM
VANESSA KUBO	Officer	Sep 01 '26	Proposed Sale	63.05	30,846	1,944,840		Sep 01 04:42 PM
West Nadja	Director	Aug 28 '26	Sale	69.00	3,000	207,000	31,981	Sep 01 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 25 '26	Sale	69.87	11,848	827,857	150,000	Aug 27 08:28 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 25 '26	Sale	68.39	238,152	16,286,612	161,848	Aug 27 08:27 PM
Eric Lefkofsky	Officer	Aug 25 '26	Proposed Sale	66.17	250,000	16,542,500		Aug 25 04:57 PM
Fukushima Ryan	CEO, Data	Aug 21 '26	Sale	70.00	14,286	1,000,020	47,420	Aug 25 04:15 PM
VANESSA KUBO	Officer	Aug 21 '26	Proposed Sale	66.65	14,286	952,162		Aug 21 04:34 PM
THOMAS SCHOENHERR	Officer	Aug 21 '26	Proposed Sale	66.65	2,694	179,555		Aug 21 04:33 PM
Fukushima Ryan	CEO, Data	Aug 18 '26	Sale	49.61	41,095	2,038,723	562,463	Aug 20 09:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 18 '26	Sale	49.61	132,591	6,577,840	2,098,130	Aug 20 09:00 PM
Schoenherr Thomas Edward	CEO, Diagnostics	Aug 19 '26	Sale	58.40	8,082	471,991	89,715	Aug 20 09:00 PM
Schoenherr Thomas Edward	CEO, Diagnostics	Aug 18 '26	Sale	49.61	9,232	458,000	97,797	Aug 20 09:00 PM
Rogers James William	Chief Financial Officer	Aug 19 '26	Sale	60.00	26,313	1,578,780	106,024	Aug 20 09:00 PM
Rogers James William	Chief Financial Officer	Aug 18 '26	Sale	49.61	22,529	1,117,664	132,337	Aug 20 09:00 PM
Polovin Andrew	EVP, Chief Legal Officer	Aug 18 '26	Sale	49.61	22,148	1,098,762	146,067	Aug 20 09:00 PM
Polovin Andrew	EVP, Chief Legal Officer	Aug 19 '26	Sale	56.00	7,927	443,912	138,140	Aug 20 09:00 PM
Bartolucci Ryan M	Chief Accounting Officer	Aug 18 '26	Sale	49.61	6,175	306,342	67,866	Aug 20 09:00 PM
Eric Paul Lefkofsky	Officer	Aug 18 '26	Proposed Sale	51.64	132,591	6,846,999		Aug 19 05:03 PM
Andrew Polovin	Officer	Aug 18 '26	Proposed Sale	51.64	22,148	1,143,723		Aug 19 05:02 PM
Ryan Fukushima	Officer	Aug 18 '26	Proposed Sale	51.64	41,095	2,122,146		Aug 19 05:01 PM
Ryan M. Bartolucci	Officer	Aug 18 '26	Proposed Sale	51.64	6,175	318,877		Aug 19 04:59 PM
James William Rogers	Officer	Aug 18 '26	Proposed Sale	51.64	22,529	1,163,398		Aug 19 04:58 PM
Thomas Edward Schoenherr	Officer	Aug 18 '26	Proposed Sale	51.64	9,232	476,740		Aug 19 04:56 PM
JAMES ROGERS	Officer	Aug 19 '26	Proposed Sale	49.36	26,313	1,298,810		Aug 19 04:38 PM
ANDREW POLOVIN	Officer	Aug 19 '26	Proposed Sale	49.36	7,927	391,277		Aug 19 04:32 PM
THOMAS SCHOENHERR	Officer	Aug 19 '26	Proposed Sale	49.36	8,082	398,928		Aug 19 04:31 PM
West Nadja	Director	Aug 14 '26	Sale	53.90	3,000	161,700	34,981	Aug 18 04:15 PM
NADJA WEST	Director	Aug 14 '26	Proposed Sale	54.29	6,000	325,740		Aug 14 04:42 PM
Fukushima Ryan	CEO, Data	Aug 07 '26	Sale	50.04	20,000	1,000,800	123,945	Aug 11 05:29 PM
VANESSA KUBO	Officer	Aug 07 '26	Proposed Sale	46.12	20,000	922,400		Aug 07 04:36 PM
Epstein David R	Director	Aug 03 '26	Sale	43.40	370	16,058	31,094	Aug 05 04:30 PM
Fukushima Ryan	CEO, Data	Aug 03 '26	Sale	46.19	23,818	1,100,076	143,945	Aug 05 04:30 PM
DAVID R. EPSTEIN	Director	Aug 03 '26	Proposed Sale	43.87	990	43,431		Aug 03 04:48 PM
VANESSA KUBO	Officer	Aug 03 '26	Proposed Sale	43.87	23,818	1,044,896		Aug 03 04:17 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jul 28 '26	Sale	42.06	250,000	10,514,914	200,000	Jul 30 09:42 PM
Eric Lefkofsky	Officer	Jul 28 '26	Proposed Sale	42.91	250,000	10,727,500		Jul 28 04:40 PM
Fukushima Ryan	CEO, Data	Jul 08 '26	Sale	57.39	33,284	1,910,123	167,763	Jul 10 04:15 PM
VANESSA KUBO	Officer	Jul 08 '26	Proposed Sale	60.09	33,284	2,000,036		Jul 08 04:59 PM
Fukushima Ryan	CEO, Data	Jul 06 '26	Sale	60.00	10,000	600,000	201,047	Jul 08 04:15 PM
VANESSA L KUBO	Officer	Jul 06 '26	Proposed Sale	60.27	10,000	602,700		Jul 06 04:45 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 29 '26	Sale	57.48	166,250	9,556,389	8,775,283	Jul 01 04:15 PM
Doudna Jennifer A	Director	Jun 25 '26	Sale	55.00	2,673	147,015	25,942	Jun 29 08:40 PM
Rogers James William	Chief Financial Officer	Jun 25 '26	Sale	55.00	11,529	634,095	114,866	Jun 29 08:40 PM
Eric Lefkofsky	Officer	Jun 29 '26	Proposed Sale	56.14	166,250	9,333,275		Jun 29 05:52 PM
JAMES ROGERS	Officer	Jun 25 '26	Proposed Sale	51.94	11,529	598,816		Jun 25 04:25 PM
Epstein David R	Director	Jun 01 '26	Sale	49.40	250	12,350	31,464	Jun 03 04:28 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 27 '26	Sale	46.70	166,250	7,763,312	8,808,533	May 29 04:15 PM
Eric Lefkofsky	Officer	May 27 '26	Proposed Sale	46.66	166,250	7,757,225		May 27 04:45 PM
Schoenherr Thomas Edward	CEO, Diagnostics	May 19 '26	Sale	44.07	1,580	69,631	107,029	May 21 05:05 PM
Rogers James William	Chief Financial Officer	May 19 '26	Sale	44.07	10,853	478,292	126,395	May 21 05:05 PM
Polovin Andrew	EVP, Chief Legal Officer	May 19 '26	Sale	44.07	8,703	383,541	128,215	May 21 05:05 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 19 '26	Sale	44.07	22,335	984,303	2,230,721	May 21 05:05 PM
Fukushima Ryan	CEO, Data	May 19 '26	Sale	44.07	13,550	597,148	603,558	May 21 05:05 PM
Bartolucci Ryan M	Chief Accounting Officer	May 19 '26	Sale	44.07	4,116	181,392	74,041	May 21 05:05 PM
Ryan M. Bartolucci	Officer	May 19 '26	Proposed Sale	43.62	4,116	179,540		May 20 05:14 PM
James William Rogers	Officer	May 19 '26	Proposed Sale	43.62	10,853	473,408		May 20 05:13 PM
Erik Phelps	Officer	May 19 '26	Proposed Sale	43.62	6,418	279,953		May 20 05:11 PM
Thomas Edward Schoenherr	Officer	May 19 '26	Proposed Sale	43.62	1,580	68,920		May 20 05:09 PM
Andrew Polovin	Officer	May 19 '26	Proposed Sale	43.62	8,703	379,625		May 20 05:07 PM
Eric Paul Lefkofsky	Officer	May 19 '26	Proposed Sale	43.62	22,335	974,253		May 20 05:05 PM
Ryan Fukushima	Officer	May 19 '26	Proposed Sale	43.62	13,550	591,051		May 20 05:04 PM
LEFKOFSKY ERIC P	CEO and Chairman	Apr 28 '26	Sale	51.13	166,250	8,500,623	8,841,783	Apr 30 04:30 PM
Eric Lefkofsky	Officer	Apr 28 '26	Proposed Sale	52.68	166,250	8,758,050		Apr 28 04:41 PM
JENNIFER DOUDNA	Director	Apr 15 '26	Proposed Sale	49.53	3,348	165,826		Apr 15 04:39 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 26 '26	Sale	46.38	166,250	7,711,150	8,875,033	Mar 27 09:46 PM
Eric Lefkofsky	Officer	Mar 26 '26	Proposed Sale	46.76	166,250	7,773,850		Mar 26 04:27 PM
Epstein David R	Director	Mar 02 '26	Sale	50.69	250	12,672	25,801	Mar 04 04:30 PM
Rogers James William	Chief Financial Officer	Mar 02 '26	Sale	50.69	11,414	578,576	127,248	Mar 04 04:30 PM
JAMES ROGERS	Officer	Mar 02 '26	Proposed Sale	53.25	13,583	723,295		Mar 02 04:40 PM
DAVID R. EPSTEIN	Director	Mar 02 '26	Proposed Sale	53.25	870	46,328		Mar 02 04:38 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '26	Sale	58.87	166,250	9,787,605	8,908,283	Feb 20 09:45 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '26	Sale	59.05	13,587	802,312	1,989,626	Feb 20 09:45 PM
Phelps Erik	EVP, Chief Admin. Officer	Feb 19 '26	Sale	59.43	9,464	562,472	79,816	Feb 20 06:45 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '26	Sale	59.05	2,902	171,363	41,159	Feb 20 06:45 PM
Polovin Andrew	EVP, Chief Legal Officer	Feb 20 '26	Sale	60.31	10,949	660,292	126,918	Feb 20 06:45 PM
Polovin Andrew	EVP, Chief Legal Officer	Feb 19 '26	Sale	59.05	8,143	480,844	99,447	Feb 20 06:45 PM
Fukushima Ryan	Chief Executive Officer, Data	Feb 19 '26	Sale	59.05	9,592	566,408	694,354	Feb 20 06:45 PM
Rogers James William	Chief Financial Officer	Feb 19 '26	Sale	59.05	10,084	595,460	101,166	Feb 20 06:45 PM
ERIK PHELPS	Officer	Feb 20 '26	Proposed Sale	59.96	3,823	229,227		Feb 20 04:28 PM
ANDREW POLOVIN	Officer	Feb 20 '26	Proposed Sale	59.96	10,949	656,502		Feb 20 04:25 PM
Ryan M. Bartolucci	Officer	Feb 19 '26	Proposed Sale	56.16	2,902	162,976		Feb 19 09:24 PM
Andrew Polovin	Officer	Feb 19 '26	Proposed Sale	56.16	8,143	457,311		Feb 19 09:22 PM
Eric Paul Lefkofsky	Officer	Feb 19 '26	Proposed Sale	56.16	13,587	763,046		Feb 19 09:20 PM
Ryan Fukushima	Officer	Feb 19 '26	Proposed Sale	56.16	9,592	538,687		Feb 19 09:17 PM
Erik Phelps	Officer	Feb 19 '26	Proposed Sale	56.16	5,650	317,304		Feb 19 09:15 PM
James William Rogers	Officer	Feb 19 '26	Proposed Sale	56.16	10,084	566,317		Feb 19 09:13 PM
ERIK PHELPS	Officer	Feb 19 '26	Proposed Sale	56.16	3,814	214,194		Feb 19 04:43 PM
Eric Lefkofsky	Officer	Feb 19 '26	Proposed Sale	56.16	166,250	9,336,600		Feb 19 04:08 PM
Tempus AI, Inc.	10% Owner	Nov 18 '25	Buy	7.67	64,750	496,632	12,783,550	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 25 '25	Buy	10.62	23,600	250,665	12,918,346	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 22 '25	Buy	8.93	28,000	250,040	13,039,067	Feb 13 05:24 PM

Open in Screener

PODD

Insulet Corp

140.60

Sep 18 • 3:59 PM ET -0.95 (-0.67%)

141.50

Aftermarket • 7:31 PM ET +0.90 (0.64%)

Healthcare Medical Devices USA Mid NASD

Peers: DXCM TNDM GKOS MDT BSX ABT SYK ALGN RMD ISRG

| Held by: VTI VOO VB RSP VBK IVV SPY XLV IWP IHI

Index	S&P 500
Market Cap	9.75B
Enterprise Value	10.16B
Income	375.30M
Sales	3.05B
Book/sh	20.51
Cash/sh	7.71
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	5400
IPO	May 15, 2007

P/E	27.87
Forward P/E	18.23
PEG	0.79
P/S	3.19
P/B	6.86
P/C	18.23
P/FCF	33.19
EV/EBITDA	15.89
EV/Sales	3.33
Quick Ratio	1.80
Current Ratio	2.45
Debt/Eq	0.67
LT Debt/Eq	0.65
Option/Short	Yes / Yes

EPS (ttm)	5.04
EPS next Y	7.71
EPS next Q	1.59
EPS this Y	30.85%
EPS next Y	18.57%
EPS next 5Y	23.16%
EPS past 3/5Y	275.33% 102.14%
Sales past 3/5Y	27.54% 24.53%
EPS Y/Y TTM	59.39%
Sales Y/Y TTM	29.41%
EPS Q/Q	234.76%
Sales Q/Q	23.51%
Earnings	Aug 05 BMO
EPS/Sales Surpr.	13.11% 1.82%

Insider Own	0.43%
Insider Trans	2.38%
Inst Own	106.95%
Inst Trans	1.39%
ROA	11.31%
ROE	26.02%
ROIC	15.96%
Gross Margin	72.16%
Oper. Margin	16.88%
Profit Margin	12.29%
SMA20	-1.62%
SMA50	-6.68%
SMA200	-30.28%
Trades

Shs Outstand	69.35M
Shs Float	69.06M
Short Float	6.44%
Short Ratio	2.67
Short Interest	4.45M
52W High	354.88 -60.38%
52W Low	126.40 11.23%
Volatility	3.14% 3.49%
ATR (14)	5.33
RSI (14)	45.19
Beta	1.09
Rel Volume	1.50
Avg Volume	1.67M
Volume	2,506,360

Perf Week	6.55%
Perf Month	-7.20%
Perf Quarter	-3.54%
Perf Half Y	-38.50%
Perf YTD	-50.53%
Perf Year	-57.84%
Perf 3Y	-17.77%
Perf 5Y	-51.92%
Perf 10Y	230.98%
Recom	2.04
Target Price	169.86
Prev Close	141.55
Price	140.60
Change %	-0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$144
Aug-06-26	Downgrade	Truist	Buy → Hold	$153
Aug-06-26	Downgrade	Leerink Partners	Outperform → Market Perform	$145
Aug-06-26	Downgrade	JP Morgan	Overweight → Neutral	$152
Aug-06-26	Downgrade	BTIG Research	Buy → Neutral
Aug-05-26	Downgrade	Oppenheimer	Outperform → Perform
Jul-28-26	Resumed	UBS	Neutral	$174
Jun-23-26	Initiated	Deutsche Bank	Buy	$190
May-20-26	Resumed	William Blair	Outperform
Apr-24-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$220
Apr-07-26	Downgrade	Citigroup	Buy → Neutral	$230
Jan-27-26	Resumed	TD Cowen	Hold	$294
Jan-12-26	Downgrade	Barclays	Overweight → Equal Weight	$274
Dec-16-25	Initiated	Evercore ISI	Outperform	$370
Nov-19-25	Upgrade	UBS	Neutral → Buy	$400
Oct-21-25	Resumed	Stifel	Buy	$370
Sep-08-25	Resumed	Oppenheimer	Outperform	$365
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350

Show Previous Ratings

Sep-18-26 07:00AM	Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum (Business Wire)
Sep-14-26 02:16PM	Why Pay More For Stryker When BSX Stock Is On Sale? (Trefis)
11:22AM	Beta Bionics insulin patch pump gets FDA nod (MedTech Dive)
Sep-01-26 07:47AM	MiniMed submits new patch pump for FDA clearance (MedTech Dive)
Aug-26-26 04:33PM	Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution (PR Newswire)
07:00AM	Loading…
07:00AM	Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference (Business Wire)
Aug-18-26 04:30PM	Insulet Corp. stock outperforms competitors on strong trading day (MarketWatch) +5.96%
Aug-13-26 04:38AM	Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD (PR Newswire)
Aug-06-26 09:48AM	Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls (The Fly)
08:50AM	JPMorgan cuts Insulet to neutral on slowing U.S. growth, trims target by 45% (Investing.com)
Aug-05-26 06:42PM	Insulet Corporation Q2 2026 Earnings Call Summary (Moby) -20.12%
04:54PM	Insulet Stock Crashes as Tiny Guidance Cut Changes the Story (GuruFocus.com)
04:30PM	Insulet Corp. stock underperforms Wednesday when compared to competitors (MarketWatch)
03:03PM	Insulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Offset by Type 2 ... (GuruFocus.com)
12:17PM	This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today. (Barrons.com)
10:45AM	Loading…
10:45AM	Insulet Reports Second-Quarter Revenue Growth as Full-Year U.S. Omnipod Outlook Is Lowered (InvestorsHub)
07:09AM	Insulet: Q2 Earnings Snapshot (Associated Press)
07:00AM	Insulet Reports Second Quarter 2026 Results (Business Wire)
Jul-29-26 08:27AM	Can Stocks Defy the Upcoming Bearish Seasonality? (Schaeffer's Research)
Jul-20-26 12:43PM	Goldman Flags 3 AI-Resistant Investment Themes to Watch (Barrons.com)
Jul-15-26 04:59AM	Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD (PR Newswire)
Jul-14-26 03:00AM	Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss (Business Wire)
Jul-13-26 05:14PM	PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses (PR Newswire)
Jul-10-26 08:08AM	DXCM Grew. The Stock Did Not. Someone Is Wrong (Trefis)
Jul-08-26 05:38PM	Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM (Exec Edge)
Jul-07-26 09:22AM	How To Target A 10% Yield While Catching The BSX Stock Knife? (Trefis)
07:10AM	Insulet launches Omnipod 5 in Spain (MedTech Dive)
Jul-01-26 07:00AM	Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026 (Business Wire)
Jun-25-26 07:00AM	Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors (Business Wire)
Jun-09-26 04:30PM	Insulet Corp. stock outperforms competitors on strong trading day (MarketWatch) +5.35% -5.58%
07:00AM	Loading…
Jun-06-26 07:00AM	Insulet Reveals New Data Supporting Breakthrough Omnipod 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care (Business Wire)
Jun-05-26 06:25AM	Dexcom buys Nutrisense; Insulet rolls out patch pump update (MedTech Dive)
Jun-04-26 07:00AM	Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions (Business Wire)
Jun-03-26 07:00AM	Insulet Announces U.S. Rollout of Enhanced Omnipod 5 Algorithm and Expands Compatibility with Abbotts FreeStyle Libre 3 Plus Sensor (Business Wire)
Jun-01-26 03:42AM	Court overturns Insulets $59M trade secret verdict against EOFlow (MedTech Dive)
May-28-26 11:28AM	PODD and Omnipod 5: What's Driving Insulet's 2026 Growth (Quartz)
08:03AM	BSX Stock: Don't Try To Catch The Falling Knife (Trefis)
May-27-26 04:30PM	Insulet Corp. stock underperforms Wednesday when compared to competitors (MarketWatch) -5.07%
04:05PM	Insulet to Participate in William Blair 46th Annual Growth Stock Conference (Business Wire)
07:29AM	Insulet recalls 7M patch pumps due to leak risk (MedTech Dive)
07:29AM	Insulet recalls 7 million patch pumps due to leak risk (MedTech Dive)
May-26-26 04:05PM	Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod Pods in the U.S. and Affected International Markets (Business Wire)
06:15AM	Beta Bionics to launch its first insulin patch pump to compete with Insulet (MedTech Dive)
May-19-26 11:52AM	Is BSX Stock A Value Trap Or A Rebound Play? (Trefis)
May-13-26 04:30PM	Insulet Corp. stock underperforms Wednesday when compared to competitors (MarketWatch) -6.01%
May-12-26 09:56AM	Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls (The Fly)
May-06-26 01:00PM	Insulet Corporation Q1 2026 Earnings Call Summary (Moby) -9.70%
07:33AM	Insulet raises revenue expectations for 2026 (MedTech Dive)
07:16AM	Insulet: Q1 Earnings Snapshot (Associated Press)
07:00AM	Insulet Reports First Quarter 2026 Results (Business Wire)
May-05-26 07:00AM	Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities (Business Wire)
May-04-26 07:00AM	Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes (Business Wire)
Apr-28-26 07:00AM	Insulet to Participate in BofA Securities 2026 Health Care Conference (Business Wire)
Apr-24-26 09:44AM	Intel upgraded, DraftKings downgraded: Wall Street's top analyst calls (The Fly)
Apr-23-26 11:54AM	Why BSX Stock's Q1 Beat Is A Lagging Indicator (Trefis)
Apr-01-26 07:00AM	Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026 (Business Wire)
Mar-31-26 03:09PM	MiniMed initiated with Buy rating by Bank of America on pipeline-driven growth outlook (Proactive)
06:30AM	Can Boston Scientific Stock Surge 40% From Here? (Trefis)
Mar-13-26 04:45PM	Iran War Drags Stocks Lower (Barchart) -6.88%
01:08PM	Insulet initiates Omnipod 5 recall following 18 AE reports (Medical Device Network)
11:18AM	Stocks Erase Early Gains on Iran War Anxiety (Barchart)
07:31AM	Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps (MedTech Dive)
Mar-12-26 04:05PM	Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S. (Business Wire)
Mar-11-26 04:01PM	Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes (Business Wire)
05:26AM	Insulet price target lowered to $338 from $345 at Citi (TipRanks)
Mar-10-26 07:00AM	Insulet to Present EVOLUTION 2 Results on Omnipod Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) (Business Wire)
Mar-03-26 09:10AM	Medtronic Debuts MiniMed Go Smart MDI With Simplera Sensor in Europe (Zacks)
Feb-26-26 10:29PM	Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating (Insider Monkey)
Feb-24-26 11:33AM	AdvaMed names Jake Leach as chair of diabetes sector (MedTech Dive)
06:25AM	Medtronics MiniMed prices IPO at up to $784M (MedTech Dive)
Feb-23-26 03:46PM	O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD) (Insider Monkey)
Feb-20-26 05:00AM	Senseonics launches automated insulin dosing system with 1-year CGM (MedTech Dive)
Feb-19-26 08:09AM	PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
12:31AM	PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance (StockStory)
Feb-18-26 04:33PM	Stocks Settle Higher on Signs of US Economic Strength (Barchart)
02:00PM	Insulet Corp (PODD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
01:57PM	Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars (Benzinga)
12:26PM	Insulet (PODD) Shares Skyrocket, What You Need To Know (StockStory)
11:40AM	Analyst Report: Insulet Corporation (Morningstar Research)
09:36AM	Insulet Q4 Earnings Call Highlights (MarketBeat)
09:30AM	Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:15AM	Insulet (PODD) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:37AM	Insulet beats revenue expectations in fourth quarter, shares rise (Investing.com)
07:27AM	Insulet: Q4 Earnings Snapshot (Associated Press Finance)
07:07AM	Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales (StockStory)
07:00AM	Insulet Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-17-26 05:35PM	AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates (Zacks)
Feb-16-26 10:04PM	Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow (StockStory)
Feb-15-26 06:53AM	Insulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update (Insider Monkey)
Feb-13-26 04:36PM	Analyst Report: DexCom, Inc. (Morningstar Research)
11:26AM	Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market (PR Newswire)
Feb-12-26 09:15AM	Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-11-26 10:00AM	Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-10-26 07:40AM	Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates (Zacks)
Feb-05-26 07:00AM	Insulet Launches Omnipod 5 and Omnipod Discover in the Middle East to Transform Diabetes Care (Business Wire)
Feb-02-26 07:50PM	Insulet Corporation (PODD): A Bull Case Theory (Insider Monkey)
Jan-30-26 02:31PM	Reasons Why Hedge Funds Favor Insulet Corp (PODD) (Insider Monkey)
Jan-29-26 09:08PM	Analyst Report: Insulet Corporation (Morningstar Research)
Jan-27-26 09:37AM	Target upgraded, Stryker downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Affirm Holdings, Alcoa, Block, Coinbase Global,CoreWeave, Datadog, Intuitive Surgical, and More (24/7 Wall St.)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

CEOMs. Ashley A. McEvoy

Executive VP & CFOMs. Flavia H. Pease

Executive VP & COOMr. Eric Benjamin

Senior VP & General CounselMr. John Wodick Kapples J.D.

Senior Vice President of Global OperationsMr. Prem Singh

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McEvoy Ashley	President and CEO	Aug 21 '26	Buy	147.47	1,100	162,217	23,731	Aug 24 07:08 AM
STONESIFER TIMOTHY C.	Director	Jun 03 '26	Buy	143.51	2,790	400,393	9,041	Jun 04 04:25 PM
BORIO LUCIANA	Director	Jun 03 '26	Sale	143.27	418	59,887	4,329	Jun 04 04:23 PM
WEATHERMAN ELIZABETH H	Director	Jun 03 '26	Buy	144.20	3,450	497,490	10,352	Jun 03 04:19 PM
BORIO LUCIANA	Director	Jun 03 '26	Proposed Sale	143.26	418	59,885		Jun 03 03:07 PM
MINOGUE MICHAEL R	Director	Feb 25 '26	Buy	246.23	2,030	499,847	17,483	Feb 26 07:05 AM
McEvoy Ashley	President and CEO	Feb 20 '26	Buy	239.35	4,300	1,029,205	13,916	Feb 23 08:14 AM
Frederick Wayne A.I.	Director	Dec 15 '25	Sale	293.09	1,851	542,510	2,158	Dec 16 04:04 PM
Frederick Wayne A.I.	Director	Dec 15 '25	Proposed Sale	293.09	1,851	542,500		Dec 15 03:03 PM
STONESIFER TIMOTHY C.	Director	Dec 05 '25	Buy	311.73	962	299,884	4,591	Dec 08 04:02 PM
Manea Dan	Former Officer	Nov 26 '25	Proposed Sale	326.64	4,475	1,461,716		Nov 26 04:31 PM
Manea Dan	Former Officer	Nov 24 '25	Proposed Sale	340.95	2,306	786,228		Nov 24 04:06 PM

Open in Screener

WDAY

Workday Inc

193.87

Sep 18 • 3:59 PM ET -5.41 (-2.71%)

194.07

Aftermarket • 7:48 PM ET +0.20 (0.10%)

Technology Software - Application USA Large NASD

Peers: NOW CRM ADBE INTU SAP DDOG SNOW HUBS ORCL MSFT

| Held by: VTI VOO VO QQQ IVV VUG SPY VFLO VGT XLK

Index	NDX, S&P 500
Market Cap	46.72B
Enterprise Value	47.08B
Income	1.25B
Sales	10.16B
Book/sh	26.80
Cash/sh	14.15
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	21000
IPO	Oct 12, 2012

P/E	39.35
Forward P/E	14.64
PEG	0.78
P/S	4.60
P/B	7.23
P/C	13.70
P/FCF	16.43
EV/EBITDA	28.55
EV/Sales	4.63
Quick Ratio	0.86
Current Ratio	0.86
Debt/Eq	0.58
LT Debt/Eq	0.41
Option/Short	Yes / Yes

EPS (ttm)	4.93
EPS next Y	13.25
EPS next Q	2.74
EPS this Y	20.09%
EPS next Y	19.50%
EPS next 5Y	18.88%
EPS past 3/5Y	- -
Sales past 3/5Y	15.43% 17.27%
EPS Y/Y TTM	126.19%
Sales Y/Y TTM	13.83%
EPS Q/Q	204.05%
Sales Q/Q	13.29%
Earnings	Aug 27 AMC
EPS/Sales Surpr.	5.32% 0.49%

Insider Own	19.51%
Insider Trans	-4.35%
Inst Own	88.48%
Inst Trans	1.15%
ROA	7.40%
ROE	16.01%
ROIC	13.74%
Gross Margin	75.82%
Oper. Margin	12.64%
Profit Margin	12.31%
SMA20	-0.35%
SMA50	10.10%
SMA200	22.13%
Trades

Shs Outstand	196.00M
Shs Float	193.98M
Short Float	8.79%
Short Ratio	3.74
Short Interest	17.04M
52W High	249.85 -22.41%
52W Low	110.36 75.67%
Volatility	4.12% 3.97%
ATR (14)	8.93
RSI (14)	53.80
Beta	1.07
Rel Volume	1.72
Avg Volume	4.55M
Volume	7,810,355

Perf Week	4.40%
Perf Month	-2.29%
Perf Quarter	65.80%
Perf Half Y	45.35%
Perf YTD	-9.74%
Perf Year	-16.97%
Perf 3Y	-20.65%
Perf 5Y	-27.80%
Perf 10Y	118.00%
Recom	2.26
Target Price	211.14
Prev Close	199.28
Price	193.87
Change %	-2.71%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-26	Reiterated	Monness Crespi & Hardt	Buy	$202 → $218
Aug-28-26	Reiterated	BMO Capital Markets	Outperform	$182 → $230
Aug-28-26	Downgrade	CapitalOne	Overweight → Equal Weight	$219
Aug-17-26	Downgrade	Deutsche Bank	Buy → Hold	$220
Aug-17-26	Downgrade	BTIG Research	Buy → Neutral
Aug-10-26	Reiterated	Monness Crespi & Hardt	Buy	$150 → $202
Jul-21-26	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$145
Jul-20-26	Initiated	CLSA	Underperform	$92
Jun-25-26	Upgrade	Monness Crespi & Hardt	Neutral → Buy	$150
May-27-26	Resumed	BofA Securities	Neutral	$140
Feb-25-26	Reiterated	BMO Capital Markets	Outperform	$204 → $182
Feb-25-26	Downgrade	TD Cowen	Buy → Hold	$155
Feb-25-26	Downgrade	Evercore ISI	Outperform → In-line	$160
Feb-23-26	Downgrade	Jefferies	Buy → Hold	$150
Feb-18-26	Downgrade	Citizens	Mkt Outperform → Mkt Perform
Feb-17-26	Reiterated	BMO Capital Markets	Outperform	$285 → $204
Jan-12-26	Resumed	Goldman	Neutral	$238
Dec-17-25	Resumed	BTIG Research	Buy	$285
Dec-02-25	Initiated	Rosenblatt	Neutral	$235
Nov-21-25	Initiated	Raymond James	Mkt Perform

Show Previous Ratings

Sep-18-26 06:19PM	Workday Or Autodesk: Is The Louder AI Story The Better Stock? (Trefis)
05:51AM	Workday Stock Rallies Following Reports of Ongoing Go Private Financing Efforts (TIKR)
Sep-17-26 11:30AM	Workday Named a Leader in Inaugural 2026 Gartner Magic Quadrant for Workforce Management Technology (PR Newswire) +6.14%
09:00AM	New Research on Frontline Workers Finds Widening Expectation Gap in Schedule Flexibility, Pay Clarity and Digital Tools (PR Newswire)
Sep-16-26 10:56AM	Investment Management Platform Ridgeline Raises $250M Series E (Wealth Management)
07:06AM	Loading…
Sep-14-26 07:06AM	Workday Shares Rise 2.8% as Silver Lake Takeover Report Remains in Focus (InvestorsHub)
Sep-10-26 01:41PM	Workday Names Sarah Kennedy Ellis Chief Marketing Officer (PR Newswire)
07:18AM	Clay completes $115m Series D, valued at $7.1bn (Verdict)
05:11AM	Clay Hits $7.1B Valuation as the Revenue-Generating Agent Market Runs Hot (Forkast News)
Sep-04-26 09:07PM	AI hiring boom could turn into a surprise tailwind for software: Bernstein (Investing.com) -5.38%
Sep-02-26 11:18AM	Workday Named a Leader in 2026 Gartner Magic Quadrant for Cloud HCM Suites for 1,000+ Employee Enterprises for Eleventh Consecutive Year (PR Newswire)
09:00AM	Workday Signs a New State or Local Government Nearly Every Week as Agencies Move Off of Legacy Systems (PR Newswire)
Sep-01-26 08:30AM	Workday to Hold Annual Financial Analyst Day on October 13, 2026 (PR Newswire)
Aug-31-26 04:28AM	TEAM Stock Heads For Best Month Ever As Software Stocks Swing From SaaSpocalypse To Full Revival In One Month (Stocktwits)
Aug-30-26 08:00AM	AI isn't eating software after all - and the sector's 'epic' rally could run through October (MarketWatch)
06:20PM	Loading…
Aug-28-26 06:20PM	Workday Stock Surges After Major AI Growth Signal (GuruFocus.com) +5.76%
07:28AM	WDAY Stock Downgraded Despite Q2 Beat Analysts Flag Risk Of Another Guide Down (Stocktwits)
06:23AM	Another Day, Another Software Stock Surging 20% (Barrons.com)
06:19AM	Workday beats quarterly estimates as subscription revenue outlook broadly matches forecasts (InvestorsHub)
01:02AM	Workday Inc (WDAY) (Q2 2027) Earnings Call Highlights: AI Drives Record Growth and Strategic ... (GuruFocus.com)
Aug-27-26 09:30PM	Workday says Taiwan and Hong Kong firms lag in AI workflow integration (DigiTimes)
07:44PM	Software Stocks Slumped on AI Fears in 2026: Analysts Predict a Rebound (BeInCrypto)
05:13PM	Workday beats quarterly estimates, offers in-line outlook (Investing.com)
05:01PM	Gap, Workday, Autodesk stocks moving on Q2 earnings results (Yahoo Finance Video)
04:48PM	Workday Stock Falls As Earnings Beat, Guidance Underwhelms (Investor's Business Daily)
04:32PM	Workday Reports Higher Profit, Revenue on AI Agent Adoption (The Wall Street Journal)
04:25PM	Workday Posts Earnings Beat, Rosier Subscription Outlook. The Stock is Falling. (Barrons.com)
04:07PM	Workday: Fiscal Q2 Earnings Snapshot (Associated Press)
04:01PM	Workday Announces Fiscal 2027 Second Quarter Financial Results (PR Newswire)
04:48AM	Marvell headlines as tech, retailers and Canadian banks feature in Thursday's earnings slate (MarketWatch)
03:14PM	Loading…
Aug-25-26 03:14PM	The Paid-To-Hold Play On WDAY Stock: An 8.6% Annualized Income (Trefis)
03:05PM	BlackLine's Board Is Weighing A Sale. Here Is Who Should Be Calling. (Trefis)
Aug-24-26 08:00AM	Nvidia, software giants' earnings: What to watch the week of August 24th (Yahoo Finance Video)
Aug-20-26 02:52AM	S&P 500 Could Hit 8,000 Soon, Morningstar Says CRM, NOW, WDAY And MSFT Lead The August Rebound (Stocktwits)
Aug-19-26 05:42PM	ServiceNow's stock leads a software rally. Here's what's energizing investors. (MarketWatch)
12:00PM	Workday Introduces AI Research Team Dedicated to Advancing Reliable, Trustworthy, and Efficient Enterprise AI (PR Newswire)
Aug-18-26 09:54AM	Analyst lists 3 reasons why tech M&A may accelerate (Investing.com)
Aug-17-26 04:51PM	Workday Stock Drops 2.4% as Analysts Reject Takeover Hype (GuruFocus.com)
10:51AM	Why This Analyst Is Skeptical Of Workday-Silver Lake Deal (Investor's Business Daily)
09:36AM	Apple upgraded, Workday downgraded: Wall Street's top analyst calls (The Fly)
08:11AM	Workday Stock Is Downgraded After Buyout Report as Growth Expectations Are 'Too Optimistic' (Barrons.com)
Aug-14-26 08:03PM	HOTCHKIS & WILEY's Top Q2 2026 Move: Trimming F5 Inc at a -2.25% Portfolio Impact (GuruFocus.com)
05:13PM	Dan Ives: Workday's potential acquisition puts a floor on names in the sector (CNBC TV)
12:18PM	Workday buyout may restore confidence in battered software valuations, analysts say (Reuters)
11:04AM	Workday, Silver Lake in discussions over potential $43B deal (Proactive)
10:50AM	Whos next after Workday? Analyst names potential software M&A targets (Investing.com)
10:41AM	Software M&A heats up: Which SaaS stocks could be next for private equity? (Investing.com)
08:02AM	Silver Lakes Take-Private Plans For WDAY Could Reaccelerate Growth, Says Jefferies Ives Doesn't See A 'SaaS Apocalypse' (Stocktwits)
07:52AM	Workday takeover chatter could mark a turning point for software stocks (Yahoo Finance)
07:22AM	A Workday Takeover Bid Could End the Software Selloff (Barrons.com)
03:04AM	Silver Lake in talks to buy Workday: sources (Reuters Videos)
02:39AM	Dan Niles Says Workday Deal Could Put A Floor Under Software Stocks Palo Alto CEO Says AI Is No 'Existential Threat' To Cybersecurity (Stocktwits)
01:27AM	CRM Stock On Track For Third Week Of Gains: JPMorgan Turns Bullish On Salesforce, Sees H2 Core Business Acceleration (Stocktwits)
Aug-13-26 08:29PM	Private equity calls the AI de-rating overdone (Pitchbook) +17.78%
05:34PM	Workday's stock sees a record surge. Could a buyout spark a software revival? (MarketWatch)
04:43PM	Dow Jones Futures: S&P 500 Hits High On Workday, Sandisk, Oil Prices; Applied Materials Earnings Late (Investor's Business Daily)
04:07PM	S&P 500 Hits a New High as Sandisk, Micron Soar: Stock Market Today (Kiplinger)
04:01PM	S&P 500 Rides AI Stock Rally to Fresh Record High (Barrons.com)
03:57PM	WDAY Stock Soars To Best Day On Record PE Firm Silver Lake Reportedly In Talks To Buy Workday (Stocktwits)
03:39PM	Workday Jumps Amid Report Silver Lake In Talks To Buy Software Maker (Investor's Business Daily)
03:37PM	Workday stock surges on report of acquisition talks with Silver Lake (Yahoo Finance)
03:35PM	Workday Heads for Record Gain After Acquisition Report (The Wall Street Journal)
03:27PM	Workday Stock Soars To Best Day Ever After Report of Potential Acquisition (Barrons.com)
03:25PM	Workday's stock soars to lead the S&P 500's winners (MarketWatch)
03:15PM	Workday stock surges on Silver Lake buyout talks report (Investing.com)
02:51PM	Workday Jumps After Report Silver Lake In Talks to Buy (Bloomberg)
02:35PM	Exclusive-Silver Lake in talks to buy Workday, sources say (Reuters)
Aug-12-26 09:53AM	Palantir and Microsoft Drop. Why the AI Revival Is Hitting Software Stocks. (Barrons.com)
08:29AM	Palantir and These Software Stocks Slide in Seesaw With Chip Giants (Barrons.com)
Aug-11-26 05:27PM	Turn The ADP Shares You Own Into A 9.1% Income Stream (Trefis)
Aug-10-26 06:29PM	Googles AI Team Tells Job Seekers Its HR Filters Are Unreliable (Bloomberg)
Aug-07-26 06:01PM	Richard Pzena's Top Q2 2026 Move: Nokia Oyj at a -1.53% Portfolio Impact (GuruFocus.com) +5.52%
Aug-06-26 10:41AM	Software stocks sink, led by declines from Figma, Datadog (Yahoo Finance)
Aug-04-26 12:14PM	Don't Forget About Software Stocks This Month (Schaeffer's Research)
Aug-03-26 08:30AM	Workday to Announce Fiscal 2027 Second Quarter Financial Results on August 27, 2026 (PR Newswire)
04:13AM	WDAY, ADBE, INTU, ADSK, CRM: Software Stocks Stage Sharp Rebound In July (Stocktwits)
Jul-27-26 01:39PM	Software Is Beating Chips for Once. It May Not Be a Flash in the Pan. (Barrons.com) +9.01%
08:28AM	Dow Jones and Nasdaq make solid start to 'massive week' as oil tumbles (Proactive)
02:16AM	FTSE 100 Live: Stocks advance as oil price retreats below $90, US futures surge (Proactive)
Jul-23-26 09:23AM	Workday Adaptive Planning Achieves FedRAMP Moderate Authorization to Support Federal Workforce and Budget Planning (PR Newswire)
Jul-22-26 10:16AM	Pegasystems Just Did an IBM, Only Its AI Warning May Be Even Worse (Barrons.com) -6.20%
09:00AM	Workday Learning, Powered by Sana, Now Generally Available as an AI-Native Learning Experience Built on Workday's Trusted Data (PR Newswire)
08:12AM	Nasdaq slips and Dow climbs as investors brace for big tech earnings, Super Micro surges (Proactive)
02:16AM	FTSE 100 Live: London blue chips surge to 4-month high as inflation softens (Proactive)
Jul-21-26 11:46AM	Morgan Stanley Underweights Adobe and Workday in Software Reset (GuruFocus.com)
09:40AM	Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls (The Fly)
09:00AM	Workday Announces Rising 2026: Where Agentic HR and Agentic Finance Take Center Stage October 12-15 in Las Vegas (PR Newswire)
07:20AM	Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage (Investing.com)
06:31AM	Semiconductor stocks rebound, and other early market movers (MarketWatch)
Jul-20-26 09:39AM	Netflix upgraded, Microsoft initiated: Wall Street's top analyst calls (The Fly)
Jul-17-26 08:05AM	IBM 'did not adapt' and just lost $70B is Big Tech (and your portfolio) in trouble? Protect your nest egg now (Moneywise)
08:02AM	The Real Engine Behind ServiceNow Stock Is Its Contract Backlog (Trefis)
07:05AM	IBMs Warning Is a Hammer Slamming Down on Techs AI Outsiders (Bloomberg)
Jul-15-26 01:03PM	Turn The ADP Shares You Own Into A 9% Income Stream (Trefis)
07:51AM	Nasdaq continues rally as PayPal climbs on bid, BlackRock earnings impress (Proactive)
05:52AM	What's Next for IBM Stock After 25% Collapse (Barrons.com)
Jul-14-26 05:10PM	What IBM's profit warning means: Hardware is 'eating everyone's lunch' (MarketWatch)
03:22PM	IBM Warning Hits Software Stocks (GuruFocus.com)
02:41PM	IBM Plunge Triggers Tech Stock Selloff After Revenue Miss Warning (GuruFocus.com)
02:34PM	The Detail in IBM's Earnings Warning That Has The Stock Headed for Its Worst Day Ever (Barrons.com)

Workday, Inc. engages in the development of enterprise cloud applications for finance and human resources. The firm delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. It operates through the Cloud Applications segment. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Co-FounderMr. Aneel Bhusri

Chief Financial OfficerMr. Zane C. Rowe

Chief Legal OfficerMr. Richard Harry Sauer J.D.

President of Product & TechnologyMr. Gerrit Kazmaier

President & Chief Commercial OfficerMr. Robert Enslin

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Sep 18 '26	Proposed Sale	199.28	94,089	18,750,056		Sep 18 04:18 PM
DUFFIELD DAVID A	10% Owner	Sep 15 '26	Sale	192.28	96,545	18,563,623	105,049	Sep 17 04:24 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Sep 15 '26	Proposed Sale	194.21	96,545	18,750,004		Sep 15 04:42 PM
DUFFIELD DAVID A	10% Owner	Sep 10 '26	Sale	185.64	100,780	18,708,925	105,049	Sep 14 04:42 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Sep 10 '26	Proposed Sale	186.05	100,780	18,750,119		Sep 10 04:43 PM
DUFFIELD DAVID A	10% Owner	Sep 04 '26	Sale	198.14	90,615	17,954,368	105,049	Sep 09 05:52 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Sep 04 '26	Proposed Sale	206.92	90,615	18,750,056		Sep 04 04:28 PM
DUFFIELD DAVID A	10% Owner	Sep 01 '26	Sale	199.29	94,961	18,924,544	105,049	Sep 03 04:25 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Sep 01 '26	Proposed Sale	197.45	94,961	18,750,049		Sep 01 04:39 PM
Garfield Mark S.	Chief Accounting Officer	Jul 10 '26	Sale	142.19	918	130,530	73,718	Jul 14 07:02 PM
DUFFIELD DAVID A	10% Owner	Jul 09 '26	Sale	136.74	107,500	14,699,057	105,049	Jul 13 04:28 PM
MARK GARFIELD	Officer	Jul 10 '26	Proposed Sale	138.34	918	126,996		Jul 10 04:39 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jul 09 '26	Proposed Sale	137.88	107,500	14,822,100		Jul 09 04:26 PM
Kazmaier Gerrit S	President, Prod. and Tech.	Jul 07 '26	Sale	143.62	2,728	391,785	266,388	Jul 07 06:49 PM
Rowe Zane	Chief Financial Officer	Jul 07 '26	Sale	143.70	6,000	862,203	288,460	Jul 07 06:48 PM
Enslin Robert	President, CCO	Jul 05 '26	Sale	134.90	5,374	724,972	239,469	Jul 07 04:50 PM
DUFFIELD DAVID A	10% Owner	Jul 06 '26	Sale	135.24	107,500	14,538,267	105,049	Jul 07 04:49 PM
GERRIT KAZMAIER	Officer	Jul 07 '26	Proposed Sale	137.99	2,728	376,437		Jul 07 04:35 PM
ZANE ROWE	Officer	Jul 07 '26	Proposed Sale	137.99	12,000	1,655,880		Jul 07 04:35 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jul 06 '26	Proposed Sale	135.40	107,500	14,555,500		Jul 06 04:38 PM
Enslin Robert	Officer	Jul 06 '26	Proposed Sale	132.99	5,374	714,661		Jul 06 04:06 PM
DUFFIELD DAVID A	10% Owner	Jun 30 '26	Sale	122.04	107,500	13,119,166	105,049	Jul 01 05:02 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 30 '26	Proposed Sale	123.58	107,500	13,284,850		Jun 30 04:35 PM
DUFFIELD DAVID A	10% Owner	Jun 25 '26	Sale	115.60	107,500	12,426,606	105,049	Jun 29 04:18 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 25 '26	Proposed Sale	118.09	107,500	12,694,675		Jun 25 04:26 PM
DUFFIELD DAVID A	10% Owner	Jun 22 '26	Sale	114.25	107,500	12,281,957	105,049	Jun 24 04:15 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 22 '26	Proposed Sale	116.93	107,500	12,569,975		Jun 22 04:43 PM
DUFFIELD DAVID A	10% Owner	Jun 17 '26	Sale	124.99	107,500	13,436,122	105,049	Jun 18 04:02 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 17 '26	Proposed Sale	126.77	107,500	13,627,775		Jun 17 04:30 PM
DUFFIELD DAVID A	10% Owner	Jun 12 '26	Sale	128.52	107,500	13,815,418	105,049	Jun 15 05:00 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 12 '26	Proposed Sale	130.53	107,500	14,031,975		Jun 12 04:49 PM
DUFFIELD DAVID A	10% Owner	Jun 09 '26	Sale	138.32	107,500	14,869,715	105,049	Jun 11 07:54 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 09 '26	Proposed Sale	143.76	107,500	15,454,200		Jun 09 04:22 PM
DUFFIELD DAVID A	10% Owner	Jun 04 '26	Sale	149.56	107,500	16,077,371	105,049	Jun 08 04:22 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 04 '26	Proposed Sale	146.90	107,500	15,791,750		Jun 04 04:31 PM
DUFFIELD DAVID A	10% Owner	Jun 01 '26	Sale	156.64	107,500	16,838,803	105,049	Jun 03 05:12 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Jun 01 '26	Proposed Sale	146.19	107,500	15,715,425		Jun 01 04:21 PM
Garfield Mark S.	Chief Accounting Officer	Apr 10 '26	Sale	113.05	1,585	179,184	31,467	Apr 14 04:21 PM
DUFFIELD DAVID A	10% Owner	Apr 09 '26	Sale	112.33	107,500	12,075,839	105,049	Apr 13 05:38 PM
MARK GARFIELD	Officer	Apr 10 '26	Proposed Sale	113.06	1,585	179,200		Apr 10 04:32 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Apr 09 '26	Proposed Sale	119.17	107,500	12,810,775		Apr 09 04:22 PM
Kazmaier Gerrit S	President, Prod. and Tech.	Apr 07 '26	Sale	128.39	9,356	1,201,217	165,074	Apr 07 06:47 PM
Enslin Robert	President, CCO	Apr 06 '26	Sale	129.41	5,373	695,339	165,414	Apr 07 06:41 PM
Rowe Zane	Chief Financial Officer	Apr 07 '26	Sale	128.22	6,000	769,314	217,930	Apr 07 06:40 PM
DUFFIELD DAVID A	10% Owner	Apr 06 '26	Sale	129.60	107,500	13,932,089	105,049	Apr 07 06:38 PM
GERRIT KAZMAIER	Officer	Apr 07 '26	Proposed Sale	129.72	9,356	1,213,660		Apr 07 04:28 PM
ZANE ROWE	Officer	Apr 07 '26	Proposed Sale	129.72	6,000	778,320		Apr 07 04:27 PM
DAVID A. DUFFIELD TRUST U/T/A	10% Owner	Apr 06 '26	Proposed Sale	132.26	107,500	14,217,950		Apr 06 04:27 PM
Enslin Robert	Officer	Apr 06 '26	Proposed Sale	131.97	5,373	709,075		Apr 06 04:03 PM
DUFFIELD DAVID A	10% Owner	Mar 31 '26	Sale	129.76	107,500	13,949,215	105,049	Apr 02 04:26 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 31 '26	Proposed Sale	128.77	107,500	13,842,775		Mar 31 04:21 PM
DUFFIELD DAVID A	10% Owner	Mar 26 '26	Sale	128.35	107,500	13,797,430	105,049	Mar 30 06:07 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 26 '26	Proposed Sale	127.07	107,500	13,660,025		Mar 26 04:23 PM
DUFFIELD DAVID A	10% Owner	Mar 23 '26	Sale	136.82	107,500	14,708,651	105,049	Mar 25 04:37 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 23 '26	Proposed Sale	135.96	107,500	14,615,700		Mar 23 04:36 PM
DUFFIELD DAVID A	10% Owner	Mar 18 '26	Sale	132.58	107,500	14,252,009	105,049	Mar 20 04:52 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 18 '26	Proposed Sale	135.17	107,500	14,530,775		Mar 18 04:30 PM
DUFFIELD DAVID A	10% Owner	Mar 13 '26	Sale	132.67	107,500	14,262,350	105,049	Mar 17 05:44 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 13 '26	Proposed Sale	134.14	107,500	14,420,050		Mar 13 04:22 PM
DUFFIELD DAVID A	10% Owner	Mar 10 '26	Sale	142.18	107,500	15,284,227	105,049	Mar 12 04:39 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 10 '26	Proposed Sale	148.14	107,500	15,925,050		Mar 10 04:34 PM
DUFFIELD DAVID A	10% Owner	Mar 05 '26	Sale	147.16	107,500	15,819,244	105,049	Mar 09 04:28 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 05 '26	Proposed Sale	143.04	107,500	15,376,800		Mar 05 04:28 PM
DUFFIELD DAVID A	10% Owner	Mar 02 '26	Sale	134.40	107,500	14,447,900	105,049	Mar 04 05:38 PM
DAVID A DUFFIELD TRUST U/T/A 7	10% Owner	Mar 02 '26	Proposed Sale	133.76	107,500	14,379,200		Mar 02 04:39 PM
DUFFIELD DAVID A	10% Owner	Jan 08 '26	Sale	209.75	82,884	17,385,197	105,049	Jan 09 07:50 PM
Garfield Mark S.	Chief Accounting Officer	Jan 08 '26	Sale	209.56	953	199,711	35,336	Jan 09 07:49 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 08 '26	Proposed Sale	211.14	82,884	17,500,128		Jan 08 04:23 PM
MARK GARFIELD	Officer	Jan 08 '26	Proposed Sale	211.14	953	201,216		Jan 08 04:22 PM
Eschenbach Carl M.	CEO	Jan 05 '26	Sale	210.00	3,125	656,250	17,097	Jan 07 06:58 PM
Kazmaier Gerrit S	President, Prod. and Tech.	Jan 06 '26	Sale	208.73	3,759	784,626	105,167	Jan 07 05:21 PM
Enslin Robert	President, CCO	Jan 05 '26	Sale	210.17	22,185	4,662,713	106,330	Jan 07 05:20 PM
Rowe Zane	Chief Financial Officer	Jan 06 '26	Sale	208.75	6,000	1,252,492	159,158	Jan 07 05:16 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Jan 06 '26	Sale	210.00	1,130	237,300	85,398	Jan 07 05:15 PM
ZANE ROWE	Officer	Jan 06 '26	Proposed Sale	208.90	6,000	1,253,400		Jan 06 04:32 PM
GERRIT KAZMAIER	Officer	Jan 06 '26	Proposed Sale	208.90	3,759	785,255		Jan 06 04:30 PM
RICHARD SAUER	Officer	Jan 06 '26	Proposed Sale	208.90	1,130	236,057		Jan 06 04:25 PM
DUFFIELD DAVID A	10% Owner	Jan 02 '26	Sale	205.29	81,479	16,727,042	105,049	Jan 06 04:23 PM
C ESCHENBACH JR. & A ESCHENBAC	Director	Jan 05 '26	Proposed Sale	205.79	3,125	643,094		Jan 05 04:41 PM
Enslin Robert	Officer	Jan 05 '26	Proposed Sale	205.80	22,185	4,565,673		Jan 05 04:07 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 02 '26	Proposed Sale	214.78	81,479	17,500,060		Jan 02 04:26 PM
DUFFIELD DAVID A	10% Owner	Dec 23 '25	Sale	215.04	80,279	17,262,992	105,049	Dec 29 04:42 PM
Kazmaier Gerrit S	President, Prod. and Tech.	Dec 19 '25	Sale	218.77	6,547	1,432,258	111,353	Dec 23 04:27 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 23 '25	Proposed Sale	217.99	80,279	17,500,019		Dec 23 04:20 PM
GERRIT KAZMAIER	Officer	Dec 19 '25	Proposed Sale	218.08	6,547	1,427,770		Dec 19 04:21 PM
DUFFIELD DAVID A	10% Owner	Dec 16 '25	Sale	215.98	81,434	17,588,334	105,049	Dec 18 04:19 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 16 '25	Proposed Sale	214.90	81,434	17,500,167		Dec 16 04:31 PM
The Dave & Cheryl Duffield Fou	10% Owner	Dec 15 '25	Proposed Sale	224.49	15,000	3,367,350		Dec 15 04:14 PM
DUFFIELD DAVID A	10% Owner	Dec 02 '25	Sale	212.19	82,025	17,404,800	105,049	Dec 04 04:25 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 02 '25	Proposed Sale	213.35	82,025	17,500,034		Dec 02 04:25 PM
Garfield Mark S.	Chief Accounting Officer	Oct 09 '25	Sale	238.96	1,915	457,601	37,351	Oct 14 04:34 PM
MCNAMARA MICHAEL M	Director	Oct 10 '25	Sale	235.16	5,393	1,268,201	24,078	Oct 14 04:32 PM
DUFFIELD DAVID A	10% Owner	Oct 08 '25	Sale	236.34	75,053	17,738,401	102,997	Oct 10 04:31 PM
Michael McNamara	Director	Oct 10 '25	Proposed Sale	235.16	5,393	1,268,201		Oct 10 04:20 PM
MARK GARFIELD	Officer	Oct 09 '25	Proposed Sale	238.25	1,915	456,249		Oct 09 04:18 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 08 '25	Proposed Sale	233.17	75,053	17,500,108		Oct 08 04:20 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Oct 07 '25	Sale	235.87	2,320	547,220	90,077	Oct 07 07:41 PM
Rowe Zane	Chief Financial Officer	Oct 07 '25	Sale	232.62	6,000	1,395,717	168,468	Oct 07 06:48 PM
RICHARD SAUER	Officer	Oct 07 '25	Proposed Sale	238.36	2,320	552,995		Oct 07 04:41 PM
Eschenbach Carl M.	CEO	Oct 01 '25	Sale	237.52	6,250	1,484,504	20,222	Oct 03 06:43 PM

TEM

Tempus AI Inc

PODD

Insulet Corp

WDAY

Workday Inc

Upgrade your Finviz experience